Management of Cardiovascular Diseases by Short-Chain Fatty Acid Postbiotics Publisher



Mousavi Ghahfarrokhi SS^{1, 2, 3, 4} ; Mohamadzadeh M⁵ ; Samadi N^{1, 2} ; Fazeli MR^{1, 2} ; Khaki S⁶ ; Khameneh B⁷ ; Khameneh Bagheri R⁶
Source: Current Nutrition Reports Published:2024

Abstract

Purpose of Review: Global health concerns persist in the realm of cardiovascular diseases (CVDs), necessitating innovative strategies for both prevention and treatment. This narrative review aims to explore the potential of short-chain fatty acids (SCFAs)—namely, acetate, propionate, and butyrate—as agents in the realm of postbiotics for the management of CVDs. Recent Findings: We commence our discussion by elucidating the concept of postbiotics and their pivotal significance in mitigating various aspects of cardiovascular diseases. This review centers on a comprehensive examination of diverse SCFAs and their associated receptors, notably GPR41, GPR43, and GPR109a. In addition, we delve into the intricate cellular and pharmacological mechanisms through which these receptors operate, providing insights into their specific roles in managing cardiovascular conditions such as hypertension, atherosclerosis, heart failure, and stroke. Summary: The integration of current information in our analysis highlights the potential of both SCFAs and their receptors as a promising path for innovative therapeutic approaches in the field of cardiovascular health. The idea of postbiotics arises as an optimistic and inventive method, presenting new opportunities for preventing and treating cardiovascular diseases. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.